{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:29:28Z","timestamp":1776695368795,"version":"3.51.2"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA201129P1"],"award-info":[{"award-number":["CA201129P1"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA240515"],"award-info":[{"award-number":["R01CA240515"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS119231"],"award-info":[{"award-number":["R01-NS119231"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS124607"],"award-info":[{"award-number":["R01-NS124607"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001445","name":"Alex's Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006064","name":"Sontag Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08CA234416"],"award-info":[{"award-number":["K08CA234416"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA258346"],"award-info":[{"award-number":["R37CA258346"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R50CA251960"],"award-info":[{"award-number":["R50CA251960"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008222","name":"Ben and Catherine Ivy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008222","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.neo.2023.100881","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T18:27:29Z","timestamp":1675103249000},"page":"100881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5880-1033","authenticated-orcid":false,"given":"Leslie A.","family":"Parsels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Koschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5008-4327","authenticated-orcid":false,"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neo.2023.100881_bib0001","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/neuonc\/noaa295","article-title":"Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017","volume":"23","author":"Patil","year":"2021","journal-title":"Neuro. Oncol."},{"issue":"1","key":"10.1016\/j.neo.2023.100881_bib0002","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/neuonc\/nou104","article-title":"Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria","volume":"17","author":"Jansen","year":"2015","journal-title":"Neuro. Oncol."},{"issue":"9","key":"10.1016\/j.neo.2023.100881_bib0003","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","article-title":"Contemporary survival endpoints: an international diffuse intrinsic pontine glioma registry study","volume":"19","author":"Cooney","year":"2017","journal-title":"Neuro. Oncol."},{"issue":"7384","key":"10.1016\/j.neo.2023.100881_bib0004","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neo.2023.100881_bib0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.neo.2023.100881_bib0006","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.neo.2023.100881_bib0007","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro. Oncol."},{"issue":"3","key":"10.1016\/j.neo.2023.100881_bib0008","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.adro.2019.03.009","article-title":"Role of radiation therapy in the management of diffuse intrinsic pontine glioma: a systematic review","volume":"4","author":"Gallitto","year":"2019","journal-title":"Adv. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.neo.2023.100881_bib0009","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ijrobp.2019.11.020","article-title":"Defining optimal target volumes of conformal radiation therapy for diffuse intrinsic pontine glioma","volume":"106","author":"Tinkle","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.neo.2023.100881_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0360-3016(93)90228-N","article-title":"Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study","volume":"27","author":"Freeman","year":"1993","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.neo.2023.100881_bib0011","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2016.12.007","article-title":"Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG\/DIPG working group","volume":"73","author":"Janssens","year":"2017","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.neo.2023.100881_bib0012","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.semradonc.2016.06.001","article-title":"Translation of targeted radiation sensitizers into clinical trials","volume":"26","author":"Reichert","year":"2016","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.neo.2023.100881_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.679701","article-title":"The evolving role of radiotherapy for pediatric cancers with advancements in molecular tumor characterization and targeted therapies","volume":"11","author":"Shen","year":"2021","journal-title":"Front. Oncol."},{"issue":"18","key":"10.1016\/j.neo.2023.100881_bib0014","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1016\/j.ejca.2013.08.006","article-title":"Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy\u2013results of a United Kingdom phase II trial (CNS 2007 04)","volume":"49","author":"Bailey","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.neo.2023.100881_bib0015","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.ijrobp.2012.09.004","article-title":"Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study","volume":"85","author":"Bradley","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.neo.2023.100881_bib0016","doi-asserted-by":"crossref","first-page":"E627","DOI":"10.1016\/j.ijrobp.2019.06.1068","article-title":"Retrospective analysis of radiotherapy with or without concurrent and adjuvant temozolomide in newly diagnosed paediatric diffuse intrinsic pontine glioma","volume":"105","author":"Pandya","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"29","key":"10.1016\/j.neo.2023.100881_bib0017","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.19.00730","article-title":"Dose escalation trial of the WEE1 Inhibitor Adavosertib (AZD1775) in combination with gemcitabine and radiation for patients with locally advanced pancreatic cancer","volume":"37","author":"Cuneo","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2023.100881_bib0018","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ebiom.2018.12.060","article-title":"A phase 1 study of veliparib, a PARP-1\/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer","volume":"40","author":"Tuli","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.neo.2023.100881_bib0019","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41467-019-09140-x","article-title":"H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2\/me3 and is essential for glioma tumorigenesis","volume":"10","author":"Harutyunyan","year":"2019","journal-title":"Nat. Commun."},{"issue":"6134","key":"10.1016\/j.neo.2023.100881_bib0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.1232245","article-title":"Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma","volume":"340","author":"Lewis","year":"2013","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.neo.2023.100881_bib0021","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","article-title":"Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas","volume":"24","author":"Bender","year":"2013","journal-title":"Cancer Cell"},{"issue":"5532","key":"10.1016\/j.neo.2023.100881_bib0022","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neo.2023.100881_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.730696","article-title":"DNA double-strand break repair: all roads lead to HeterochROMAtin marks","volume":"12","author":"Caron","year":"2021","journal-title":"Front. Genet."},{"issue":"6348","key":"10.1016\/j.neo.2023.100881_bib0024","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal2380","article-title":"Epigenetic plasticity and the hallmarks of cancer","volume":"357","author":"Flavahan","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.neo.2023.100881_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2022.101899","article-title":"It's all in the combination: decoding the epigenome for cancer research and diagnostics","volume":"73","author":"Furth","year":"2022","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neo.2023.100881_bib0026","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fonc.2013.00113","article-title":"DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy","volume":"3","author":"Mladenov","year":"2013","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.neo.2023.100881_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111789","article-title":"Ionizing radiation and complex DNA damage: from prediction to detection challenges and biological significance","volume":"11","author":"Mavragani","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2023.100881_bib0028","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-med-081313-121208","article-title":"The DNA damage response: implications for tumor responses to radiation and chemotherapy","volume":"66","author":"Goldstein","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.neo.2023.100881_bib0029","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.neo.2023.100881_bib0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tcb.2015.07.009","article-title":"Repair pathway choices and consequences at the double-strand break","volume":"26","author":"Ceccaldi","year":"2016","journal-title":"Trends Cell Biol."},{"issue":"8","key":"10.1016\/j.neo.2023.100881_bib0031","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrm.2017.48","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"18","author":"Chang","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1035","key":"10.1016\/j.neo.2023.100881_bib0032","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130685","article-title":"DNA DSB repair pathway choice: an orchestrated handover mechanism","volume":"87","author":"Kakarougkas","year":"2014","journal-title":"Br. J. Radiol."},{"issue":"7120","key":"10.1016\/j.neo.2023.100881_bib0033","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.neo.2023.100881_bib0034","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.molcel.2022.05.023","article-title":"Single-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomas","volume":"82","author":"Harpaz","year":"2022","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.neo.2023.100881_bib0035","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.neo.2023.100881_bib0036","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1200\/JCO.2009.25.5463","article-title":"Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets","volume":"28","author":"Zarghooni","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.neo.2023.100881_bib0037","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.molcel.2018.08.020","article-title":"Comprehensive mapping of histone modifications at DNA double-strand breaks deciphers repair pathway chromatin signatures","volume":"72","author":"Clouaire","year":"2018","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.neo.2023.100881_bib0038","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ncb1446","article-title":"Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway","volume":"8","author":"Ziv","year":"2006","journal-title":"Nat. Cell Biol."},{"issue":"29","key":"10.1016\/j.neo.2023.100881_bib0039","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg7444","article-title":"The H3K36me2 writer-reader dependency in H3K27M-DIPG","volume":"7","author":"Yu","year":"2021","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.neo.2023.100881_bib0040","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsmb.2314","article-title":"LEDGF (p75) promotes DNA-end resection and homologous recombination","volume":"19","author":"Daugaard","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"3","key":"10.1016\/j.neo.2023.100881_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108286","article-title":"Senescence induced by BMI1 inhibition is a therapeutic vulnerability in H3K27M-mutant DIPG","volume":"33","author":"Balakrishnan","year":"2020","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.neo.2023.100881_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110536","article-title":"BMI-1 regulates DNA end resection and homologous recombination repair","volume":"38","author":"Fitieh","year":"2022","journal-title":"Cell Rep."},{"issue":"43","key":"10.1016\/j.neo.2023.100881_bib0043","doi-asserted-by":"crossref","first-page":"18475","DOI":"10.1073\/pnas.1012946107","article-title":"A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage","volume":"107","author":"Chou","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.neo.2023.100881_bib0044","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.4161\/cc.25795","article-title":"Polycomb repressive complex 2 contributes to DNA double-strand break repair","volume":"12","author":"Campbell","year":"2013","journal-title":"Cell Cycle"},{"issue":"12","key":"10.1016\/j.neo.2023.100881_bib0045","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.215525","article-title":"Histone H3K27 methylation modulates the dynamics of FANCD2 on chromatin to facilitate NHEJ and genome stability","volume":"131","author":"Zhang","year":"2018","journal-title":"J. Cell Sci."},{"issue":"10","key":"10.1016\/j.neo.2023.100881_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102813","article-title":"Radio-resistance and DNA repair in pediatric diffuse midline gliomas","volume":"12","author":"Pedersen","year":"2020","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.neo.2023.100881_bib0047","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1158\/1078-0432.CCR-18-3890","article-title":"Radiosensitization by histone H3 demethylase inhibition in diffuse intrinsic pontine glioma","volume":"25","author":"Katagi","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.neo.2023.100881_bib0048","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nm.3716","article-title":"Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma","volume":"20","author":"Hashizume","year":"2014","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.neo.2023.100881_bib0049","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nm.4296","article-title":"Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas","volume":"23","author":"Piunti","year":"2017","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.neo.2023.100881_bib0050","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.cell.2009.07.031","article-title":"Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation","volume":"138","author":"Zippo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neo.2023.100881_bib0051","doi-asserted-by":"crossref","first-page":"vi194","DOI":"10.1093\/neuonc\/noz175.810","article-title":"PDTM-34. Radiosensitization by BRD4 inhibition in diffuse intrinsic pontine glioma","volume":"21","author":"Sasaki","year":"2019","journal-title":"Neuro. Oncol."},{"issue":"9","key":"10.1016\/j.neo.2023.100881_bib0052","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/s41416-021-01321-0","article-title":"Achieving clinical success with BET inhibitors as anti-cancer agents","volume":"124","author":"Shorstova","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.neo.2023.100881_bib0053","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0715-827a","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.neo.2023.100881_bib0054","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","article-title":"Transcriptional dependencies in diffuse intrinsic pontine glioma","volume":"31","author":"Nagaraja","year":"2017","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.neo.2023.100881_bib0055","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1158\/1078-0432.CCR-19-3538","article-title":"Combined therapy of AXL and HDAC inhibition reverses mesenchymal transition in diffuse intrinsic pontine glioma","volume":"26","author":"Meel","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.neo.2023.100881_bib0056","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1158\/0008-5472.CAN-17-3691","article-title":"Dual HDAC and PI3K inhibition abrogates NF\u03baB- and FOXM1-mediated DNA damage response to radiosensitize pediatric high-grade gliomas","volume":"78","author":"Pal","year":"2018","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.neo.2023.100881_bib0057","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"The trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.neo.2023.100881_bib0058","doi-asserted-by":"crossref","first-page":"eaat1719","DOI":"10.1126\/sciadv.aat1719","article-title":"The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models","volume":"4","author":"Durant","year":"2018","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.neo.2023.100881_bib0059","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/1535-7163.MCT-19-0734","article-title":"Pharmacologic inhibitor of DNA-PK, M3814, potentiates radiotherapy and regresses human tumors in mouse models","volume":"19","author":"Zenke","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"15","key":"10.1016\/j.neo.2023.100881_bib0060","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-19-0761","article-title":"Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy","volume":"79","author":"Zhang","year":"2019","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.neo.2023.100881_bib0061","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1158\/1078-0432.CCR-20-3701","article-title":"Inhibition of DNA-PK with AZD7648 sensitizes tumor cells to radiotherapy and induces type I IFN-dependent durable tumor control","volume":"27","author":"Nakamura","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.neo.2023.100881_bib0062","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004306","article-title":"Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade","volume":"10","author":"Patin","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.neo.2023.100881_bib0063","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1158\/1541-7786.MCR-21-0725","article-title":"DNA-PK inhibition and radiation promote antitumoral immunity through RNA polymerase III in pancreatic cancer","volume":"20","author":"Wang","year":"2022","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2023.100881_bib0064","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142158","article-title":"Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models","volume":"131","author":"Deland","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2023.100881_bib0065","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.1038\/ncomms11185","article-title":"Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma","volume":"7","author":"Nikbakht","year":"2016","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.neo.2023.100881_bib0066","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1158\/1078-0432.CCR-19-0126","article-title":"TP53 pathway alterations drive radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)","volume":"25","author":"Werbrouck","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.neo.2023.100881_bib0067","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.neo.2023.100881_bib0068","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41388-021-02102-y","article-title":"Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies","volume":"41","author":"Findlay","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2023.100881_bib0069","first-page":"1","article-title":"Expanding roles of cell cycle checkpoint inhibitors in radiation oncology","author":"Hauge","year":"2021","journal-title":"Int. J. Radiat. Biol."},{"issue":"3","key":"10.1016\/j.neo.2023.100881_bib0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1158\/2159-8290.CD-13-0337","article-title":"Improving the efficacy of chemoradiation with targeted agents","volume":"4","author":"Morgan","year":"2014","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.neo.2023.100881_bib0071","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/1535-7163.MCT-12-0735","article-title":"WEE1 kinase inhibition enhances the radiation response of diffuse intrinsic pontine gliomas","volume":"12","author":"Caretti","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.neo.2023.100881_bib0072","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/neuonc\/not220","article-title":"Targeting WEE1 for the treatment of pediatric high-grade gliomas","volume":"16","author":"Mueller","year":"2014","journal-title":"Neuro. Oncol."},{"issue":"9","key":"10.1016\/j.neo.2023.100881_bib0073","doi-asserted-by":"crossref","first-page":"e29065","DOI":"10.1002\/pbc.29065","article-title":"A phase 1 study of prexasertib (LY2606368), a CHK1\/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: a report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515)","volume":"68","author":"Cash","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.neo.2023.100881_bib0074","article-title":"WEE1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: a children's oncology group phase I consortium study","volume":"4","author":"Mueller","year":"2022","journal-title":"Neurooncol. Adv."},{"issue":"10","key":"10.1016\/j.neo.2023.100881_bib0075","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41573-020-0076-6","article-title":"Poly(ADP-ribose) polymerase inhibition: past, present and future","volume":"19","author":"Curtin","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.neo.2023.100881_bib0076","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/bjc.2011.382","article-title":"The role of PARP in DNA repair and its therapeutic exploitation","volume":"105","author":"Javle","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"21","key":"10.1016\/j.neo.2023.100881_bib0077","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","article-title":"Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors","volume":"72","author":"Murai","year":"2012","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.neo.2023.100881_bib0078","doi-asserted-by":"crossref","first-page":"984","DOI":"10.18632\/oncotarget.362","article-title":"PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation","volume":"2","author":"van Vuurden","year":"2011","journal-title":"Oncotarget"},{"issue":"6330","key":"10.1016\/j.neo.2023.100881_bib0079","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.neo.2023.100881_bib0080","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/1535-7163.MCT-15-0282","article-title":"Poly-ADP-ribose polymerase as a therapeutic target in pediatric diffuse intrinsic pontine glioma and pediatric high-grade astrocytoma","volume":"14","author":"Chornenkyy","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.neo.2023.100881_bib0081","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/neuonc\/noaa016","article-title":"A phase I\/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a pediatric brain tumor consortium study","volume":"22","author":"Baxter","year":"2020","journal-title":"Neuro. Oncol."},{"issue":"5","key":"10.1016\/j.neo.2023.100881_bib0082","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00381-019-04118-y","article-title":"Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis","volume":"35","author":"Lu","year":"2019","journal-title":"Childs Nerv. Syst."},{"issue":"1","key":"10.1016\/j.neo.2023.100881_bib0083","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40478-018-0553-x","article-title":"Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma","volume":"6","author":"Lin","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.neo.2023.100881_bib0084","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/neuonc\/noy145","article-title":"Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy","volume":"21","author":"Lieberman","year":"2019","journal-title":"Neuro. Oncol."},{"issue":"8","key":"10.1016\/j.neo.2023.100881_bib0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11940-019-0577-y","article-title":"Diffuse intrinsic pontine glioma: from diagnosis to next-generation clinical trials","volume":"21","author":"Vitanza","year":"2019","journal-title":"Curr. Treat. Options Neurol."},{"issue":"3","key":"10.1016\/j.neo.2023.100881_bib0086","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11060-018-2991-5","article-title":"Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience","volume":"140","author":"Kline","year":"2018","journal-title":"J. Neurooncol."},{"issue":"3","key":"10.1016\/j.neo.2023.100881_bib0087","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2018.03.007","article-title":"Combination cancer therapy with immune checkpoint blockade: mechanisms and strategies","volume":"48","author":"Patel","year":"2018","journal-title":"Immunity"},{"issue":"14","key":"10.1016\/j.neo.2023.100881_bib0088","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019104036","article-title":"ATR inhibition potentiates ionizing radiation-induced interferon response via cytosolic nucleic acid-sensing pathways","volume":"39","author":"Feng","year":"2020","journal-title":"EMBO J."},{"issue":"7668","key":"10.1016\/j.neo.2023.100881_bib0089","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neo.2023.100881_bib0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev-immunol-032713-120156","article-title":"Innate immune sensing and signaling of cytosolic nucleic acids","volume":"32","author":"Wu","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"22","key":"10.1016\/j.neo.2023.100881_bib0091","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228877","article-title":"The impact of radiation-induced DNA damage on cGAS-STING-mediated immune responses to cancer","volume":"21","author":"Storozynsky","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.neo.2023.100881_bib0092","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41591-018-0006-x","article-title":"Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M","volume":"24","author":"Mount","year":"2018","journal-title":"Nat. Med."},{"issue":"7903","key":"10.1016\/j.neo.2023.100881_bib0093","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","article-title":"GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas","volume":"603","author":"Majzner","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.neo.2023.100881_bib0094","first-page":"82","article-title":"Abstract CT001: major tumor regressions in H3K27M-mutated diffuse midline glioma (DMG) following sequential intravenous (IV) and intracerebroventricular (ICV) delivery of GD2-CAR T cells","author":"Majzner","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2023.100881_bib0095","article-title":"B7-H3\/CD276: an emerging cancer immunotherapy","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2023.100881_bib0096","article-title":"Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety","author":"Vitanza","year":"2022","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.neo.2023.100881_bib0097","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.jamcollsurg.2020.07.021","article-title":"Radiation enhances the efficacy of B7-H3 Chimeric Antigen Receptor (CAR) T-cell based immunotherapy for Triple Negative Breast Cancer (TNBC)","volume":"231","author":"Kontos","year":"2020","journal-title":"J. Am. Coll. Surg."},{"issue":"1","key":"10.1016\/j.neo.2023.100881_bib0098","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13046-020-01773-x","article-title":"Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma","volume":"39","author":"An","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.neo.2023.100881_bib0099","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41422-020-0281-1","article-title":"Refined spatial temporal epigenomic profiling reveals intrinsic connection between PRDM9-mediated H3K4me3 and the fate of double-stranded breaks","volume":"30","author":"Chen","year":"2020","journal-title":"Cell Res."},{"issue":"25","key":"10.1016\/j.neo.2023.100881_bib0100","doi-asserted-by":"crossref","first-page":"9169","DOI":"10.1073\/pnas.1403565111","article-title":"DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin","volume":"111","author":"Ayrapetov","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.neo.2023.100881_bib0101","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.18632\/aging.101572","article-title":"H3K9me3 and H4K20me3 represent the epigenetic landscape for 53BP1 binding to DNA lesions","volume":"10","author":"Kovarikova","year":"2018","journal-title":"Aging-Us"},{"key":"10.1016\/j.neo.2023.100881_bib0102","doi-asserted-by":"crossref","first-page":"e01632","DOI":"10.7554\/eLife.01632","article-title":"Acetylation of histone H3 at lysine 64 regulates nucleosome dynamics and facilitates transcription","volume":"3","author":"Di Cerbo","year":"2014","journal-title":"Elife"},{"issue":"23-24","key":"10.1016\/j.neo.2023.100881_bib0103","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1101\/gad.331231.119","article-title":"Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity","volume":"33","author":"Kim","year":"2019","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.neo.2023.100881_bib0104","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1158\/1078-0432.CCR-21-4002","article-title":"Venetoclax cooperates with ionizing radiation to attenuate diffuse midline glioma tumor growth","volume":"28","author":"Madhavan","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2023.100881_bib0105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canlet.2017.04.019","article-title":"The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma","volume":"400","author":"Miyahara","year":"2017","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.neo.2023.100881_bib0106","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/NEN.0000000000000216","article-title":"Disrupting NOTCH slows diffuse intrinsic pontine glioma growth, enhances radiation sensitivity, and shows combinatorial efficacy with bromodomain inhibition","volume":"74","author":"Taylor","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neo.2023.100881_bib0107","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1186\/s12885-016-2690-6","article-title":"Polo-like kinase 1 as a potential therapeutic target in diffuse intrinsic pontine glioma","volume":"16","author":"Amani","year":"2016","journal-title":"BMC Cancer"},{"issue":"38","key":"10.1016\/j.neo.2023.100881_bib0108","doi-asserted-by":"crossref","first-page":"62962","DOI":"10.18632\/oncotarget.18002","article-title":"BMI-1 is a potential therapeutic target in diffuse intrinsic pontine glioma","volume":"8","author":"Kumar","year":"2017","journal-title":"Oncotarget"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558623000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558623000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:12:19Z","timestamp":1761484339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558623000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":108,"alternative-id":["S1476558623000064"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2023.100881","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2023.100881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100881"}}